Personalized Follow-Up Care for Head and Neck Cancer Patients
Individualized Follow-Up for Head and Neck Cancer
This study is testing whether giving head and neck cancer patients a choice between regular follow-up care and a personalized approach based on their needs can save money while keeping their quality of life high.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 210 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Radboud University Medical Center Academic / other |
| Locations | 1 site (Nijmegen, Gelderland) |
| Trial ID | NCT05386225 on ClinicalTrials.gov |
What this trial studies
This pilot study evaluates the feasibility of offering Head and Neck Cancer (HNC) patients a choice between standardized follow-up care and individualized follow-up after treatment. Patients will be educated on self-examination and the symptoms that warrant a follow-up visit. After 1.5 years of standard follow-up, they can opt for a personalized approach based on their symptoms and needs. The study aims to determine if this choice can save costs while maintaining quality of life for patients.
Who should consider this trial
Good fit: Ideal candidates are patients who have completed treatment for their first primary head and neck cancer and have had one year of uncomplicated routine follow-up.
Not a fit: Patients with malignant tumors of the salivary glands or those who are cognitively impaired may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower patients and potentially improve their quality of life while reducing healthcare costs.
How similar studies have performed: While similar approaches have been explored, this specific individualized follow-up model for HNC patients is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Malignant tumor of the head and neck * First primary HNC * Participant was treated with curative intent * Participant has completed one year of uncomplicated routine follow-up * Treating physician supports the possible choice for patient-led follow-up Exclusion Criteria: * Malignant tumors of salivary glands * Participant is cognitively impaired * Participant is unable to read or write in Dutch
Where this trial is running
Nijmegen, Gelderland
- Radboud University Medical Center — Nijmegen, Gelderland, Netherlands (Recruiting)
Study contacts
- Principal investigator: Robert P Takes, Prof — Radboud University Medical Center
- Study coordinator: Cecile van de Weerd, MD
- Email: cecile.vandeweerd@radboudumc.nl
- Phone: 0031243614933
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.